Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BX-004 by BiomX for Resistant Pseudomonas aeruginosa Infections: Likelihood of Approval
BX-004 is under clinical development by BiomX and currently in Phase II for Resistant Pseudomonas aeruginosa Infections. According to GlobalData,...
BX-004 by BiomX for Cystic Fibrosis: Likelihood of Approval
BX-004 is under clinical development by BiomX and currently in Phase II for Cystic Fibrosis. According to GlobalData, Phase II...
BX-004 by BiomX for Cystic Fibrosis: Likelihood of Approval
BX-004 is under clinical development by BiomX and currently in Phase II for Cystic Fibrosis. According to GlobalData, Phase II...
BX-004 by BiomX for Resistant Pseudomonas aeruginosa Infections: Likelihood of Approval
BX-004 is under clinical development by BiomX and currently in Phase II for Resistant Pseudomonas aeruginosa Infections. According to GlobalData,...